Ovid Therapeutics Inc
Follow $OVID
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $OVID by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is OVID moving today?
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
OVID overview
Related filings and maps
Congress activity in OVID
No receipt-qualified Congressional disclosure is present for OVID in the cached public ledger.
OVID contract awards, year to date.
Public federal awards linked to this ticker.
OVID lobbying filings, year to date.
Registered lobbying filings matched to Ovid Therapeutics Inc.